Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Subjects: severe asthma; real-world; Adrenal Cortex Hormones - therapeutic use

  • Source: Pavord, I, Gardiner, F, Heaney, L G, Domingo, C, Price, R G, Pullan, A, Oppenheimer, J, Brusselle, G, Nagase, H, Chupp, G, Pizzichini, E, Bañas-Conejero, D & Howarth, P 2023, ' Remission outcomes in

Record details

×

Editorial: Women in science—Regulatory science 2021

Subjects: clinical research; drug repurposing; pediatric drug development

  • Source: Thomsen, M D T & Knudsen, L E 2023, ' Editorial : Women in science—Regulatory science 2021 ', Frontiers in Medicine, vol. 10, 1159815 . https://doi.org/10.3389/fmed.2023.1159815

Record details

×

Project Optimus, an FDA initiative: Considerations for cancer drug development internationally, from an academic perspective

Subjects: Cancer Research; academic; Oncology

  • Source: Murphy, R, Halford, S & Symeonides, S N 2023, ' Project Optimus, an FDA initiative: considerations for cancer drug development internationally, from an academic

Record details

×

Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation

Subjects: HSP90 Heat-Shock Proteins/antagonists & inhibitors; Interleukin-6; Inflammation/metabolism

  • Source: Ben Abdallah, H, Seeler, S, Bregnhøj, A, Ghatnekar, G, Kristensen, L S, Iversen, L & Johansen, C 2023, ' Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation ', Frontiers in

Record details

×
  • 1-10 of  2,501 results for ""Drug""